01720oam 2200445Ia 450 991069884290332120090521121400.0(CKB)5470000002397437(OCoLC)326879738(EXLCZ)99547000000239743720090519d2005 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV), testing, product disposition, and donor deferral and reentryRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2005]ii, 41 pages digital, PDF fileTitle from PDF title page (viewed on May 19, 2009)."Draft guidance"."July 2005".Includes bibliographical references (pages 24-25).Guidance for industry Nucleic acidsUnited StatesTestingHIV (Viruses)DiagnosisUnited StatesHepatitis C virusDiagnosisUnited StatesBlood donorsGovernment policyUnited StatesNucleic acidsTesting.HIV (Viruses)DiagnosisHepatitis C virusDiagnosisBlood donorsGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOGPOBOOK9910698842903321Guidance for industry3434577UNINA